HC
GILD icon

Highmount Capital’s Gilead Sciences GILD Stock Holding History

Highmount Capital’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		$492K Hold
4,200
– – 0.13% 97
2015
Q1 		$412K Buy
4,200
+220
+6% +$22.3K 0.1% 102
2014
Q4 		$375K Hold
3,980
– – 0.09% 104
2014
Q3 		$424K Hold
3,980
– – 0.11% 104
2014
Q2 		$330K Hold
3,980
– – 0.08% 120
2014
Q1 		$282K Hold
3,980
– – 0.07% 126
2013
Q4 		$299K Hold
3,980
– – 0.07% 123
2013
Q3 		$250K Hold
3,980
– – 0.06% 118
2013
Q2 		$204K Buy
+3,980
New +$207K 0.05% 123

Other funds holding GILD

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Highmount Capital's GILD Position: Q2 2015 in Review

Highmount Capital held its Gilead Sciences (GILD) position steady in Q2 2015 at 4,200 shares worth $492K. The position accounts for 0.13% of the portfolio, ranked #97.

Highmount Capital first reported a position in GILD in Q2 2013 and has held it in 9 quarters since. 1,561 funds tracked by Wall St. Rank hold GILD as of Q2 2015.

  • Highmount Capital held 4,200 shares of Gilead Sciences worth $492K as of Q2 2015.
  • Highmount Capital left its Gilead Sciences share count unchanged in Q2 2015.
  • Gilead Sciences made up 0.13% of Highmount Capital's portfolio in Q2 2015, its #97 holding.
  • Highmount Capital first reported a position in Gilead Sciences in Q2 2013 and has held it in 9 quarters since.
  • 1,561 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2015.

Based on Highmount Capital's 13F filing for Q2 2015, filed 14 Aug 2015.